Premium
P4–319: Development of exebryl–1: A disease modifying small molecule therapeutic that causes a marked clearance of brain amyloid load and improved memory in transgenic mouse models of Alzheimer's disease
Author(s) -
Snow Alan D.,
Cummings Joel A.,
Lake Thomas P.,
Rockenstein Edward,
Masliah Eliezer
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.2060
Subject(s) - genetically modified mouse , hippocampus , transgene , morris water navigation task , amyloid (mycology) , amyloid beta , amyloid precursor protein , pharmacology , chemistry , neuroscience , alzheimer's disease , biology , medicine , pathology , disease , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom